
Ketamine Therapy Trials Navigate a Regulatory Path Distinct from Psychedelics
Ketamine and its enantiomer esketamine occupy a somewhat different regulatory and trial design position than the newer wave of psychedelic-assisted therapy compounds, partly because…






